Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | HPN | P05981 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 4/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9108657 | 0.84 | CCR6 (0.71) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL5577178 | 0.80 | CCR6 (0.66) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL4954431 | 0.78 | CCR6 (0.63) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL28192920 | 0.76 | CCR6 (0.61) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL28262952 | 0.75 | CCR6 (0.59) | CCR6MAPTALDH1A1NPSR1HPGD | |
| SCHEMBL10664728 | 0.74 | CCR6 (0.64) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL29510540 | 0.73 | CCR6 (0.68) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL11646163 | 0.73 | CCR6 (0.68) | CCR6MAPTALDH1A1HSP90AA1NPSR1 | |
| SCHEMBL20240381 | 0.72 | KMT2A (0.67) | CCR6MAPTALDH1A1NPSR1HPGD | |
| SCHEMBL11514139 | 0.72 | GPR35 (0.57) | CCR6MAPTALDH1A1NPSR1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276107-A1 | HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) | 2025-09-04 | — | — | US | claimed |
| US-8513350-B2 | Forming patterned film; radiation transparent, reduced dielectrics, solvent resistance, waterproofing, acid and alkali resistance, heat resistance, adhesives properties to substrate | JNC CORPORATION (JP) | 2013-08-20 | — | — | US | claimed |
| US-20090191386-A1 | POSITIVE PHOTOSENSITIVE POLYMER COMPOSITION | CHISSO CORPORATION (JP) | 2009-07-30 | — | — | US | claimed |
| US-20080207807-A1 | POSITIVE TYPE PHOTOSENSITIVE RESIN COMPOSITION | CHISSO CORPORATION (JP) | 2008-08-28 | — | — | US | claimed |
| EP-0527186-A4 | — | UNIV ILLINOIS (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0527186-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | The Board of Trustees for the University of Illinois (US) | 1993-02-17 | — | — | EP | claimed |
| WO-1991016820-A1 | PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1991-11-14 | — | — | WO | claimed |
| US-4318981-A | Homogeneous specific binding assay employing an intramolecularly modulated photogenic enzyme substrate label | MILES LABORATORIES, INC. (US) | 1982-03-09 | — | — | US | claimed |
| EP-4061961-B1 | METHOD FOR DOUBLE STRAND SEQUENCING | OXFORD NANOPORE TECH PLC (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | UNIV OXFORD INNOVATION LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Oxford Nanopore Technolgies PLC (GB) | 2026-03-05 | — | — | US | disclosed |
| EP-4689159-A1 | METHOD AND KITS | Oxford Nanopore Technologies PLC (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4270008-B1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECH PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| WO-2000012536-A2 | LIPID MATRIX-ASSISTED CHEMICAL LIGATION AND SYNTHESIS OF MEMBRANE POLYPEPTIDES | GRYPHON SCIENCES (US) | 2000-03-09 | — | — | WO | disclosed |
| WO-1999011655-A1 | MODULAR PROTEIN LIBRARIES AND METHODS OF PREPARATION | GRYPHON SCIENCES (US) | 1999-03-11 | — | — | WO | disclosed |
| EP-0721505-A1 | PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USE | INNOGENETICS N.V. (BE) | 1996-07-17 | — | — | EP | disclosed |
| WO-1996004385-A2 | PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USE | INNOGENETICS N.V. (BE) | 1996-02-15 | — | — | WO | disclosed |
| US-5242892-A | With 5-aminolevulinic acid | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1993-09-07 | — | — | US | disclosed |
| US-4111879-A | RESIN AND AN N-ARYL-MALEIMIDE | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | MAX, NPPA, NUP210 | CCR6 1584/4885MAPT 2775/4885ALDH1A1 4882/4885 |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, NPPA, NUP160 | CCR6 1754/4885MAPT 2543/4885ALDH1A1 4884/4885 |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, SLC9A2, SLC9A3 | CCR6 3030/4885MAPT 2784/4885ALDH1A1 4883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.